STOCK TITAN

Korsana Biosciences (KRSA) Free Cash Flow by Year

KRSA NASDAQ

Korsana Biosciences, Inc. does not report free cash flow for fiscal year 2025, so the figure is not reported on this page. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Korsana Biosciences, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow N/A

Ticker history: CYCN became KRSA (Korsana Biosciences, Inc.) on . Earlier news and filings retain their original names and dates. View CYCN history.

Source SEC Filings Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

KRSA Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20FilingFY19FilingFY18Filing
Free Cash FlowN/AN/AN/A-$40.6Mn/m-$36.5Mn/m-$74.0Mn/m-$109.1MN/A

KRSA Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'26FilingQ4'25FilingQ3'25FilingQ2'25FilingQ1'25FilingQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23Filing
Free Cash Flow-$47.1Mn/m-$1.4Mn/m-$1.2Mn/mN/A-$10.3M-$503K-$968KN/AN/AN/AN/AN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Korsana Biosciences, Inc. financials

Frequently Asked Questions

Korsana Biosciences, Inc. does not report free cash flow for fiscal year 2025, so the figure is not reported on this page.

Korsana Biosciences, Inc. (KRSA) reported -$47.1M in free cash flow in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Korsana Biosciences, Inc. (KRSA) reported on that line in every period on record.